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ABSTRACT
Correlation of motif occurrences with gene expression
intensity is an effective strategy for elucidating transcrip-
tional cis-regulatory logic. Here we demonstrate that
this approach can also identify cis-regulatory elements
for alternative pre-mRNA splicing. Using data from a
human exon microarray, we identified 56 cassette
exons that exhibited higher transcript-normalized
expression in muscle than in other normal adult
tissues. Intron sequences flanking these exons were
then analyzed to identify candidate regulatory
motifs for muscle-specific alternative splicing.
Correlation of motif parameters with gene-normalized
exon expression levels was examined using linear
regression and linear splines on RNA words and
degenerate weight matrices, respectively. Our
unbiased analysis uncovered multiple candidate reg-
ulatory motifs for muscle-specific splicing, many of
which are phylogenetically conserved among verte-
brate genomes. The most prominent downstream
motifs were binding sites for Fox1- and CELF-related
splicing factors, and a branchpoint-like element ACUAAC;
pyrimidine-rich elements resembling PTB-binding sites
were most significant in upstream introns. Intriguingly,
our systematic study indicates a paucity of novel
muscle-specific elements that are dominant in short
proximal intronic regions. We propose that Fox and
CELF proteins play major roles in enforcing the
muscle-specific alternative splicing program, facilitat-
ing expression of unique isoforms of cytoskeletal
proteins critical to muscle cell function.
INTRODUCTION
Alternative pre-mRNA splicing is a critical mechanism
for regulating gene expression in metazoan organisms,
and leads to tremendous protein diversity from a relatively
small number of genes. A majority of human genes exhibit
some form of alternative splicing. In particular, the human
genome encodes a complex alternative splicing program
that switches alternative exons on and oﬀ according to
the needs of individual diﬀerentiated cell types. Despite
intensive study in recent years, the mechanisms regulating
the human alternative splicing program are not yet well
understood. The complex decision process, involving which
subset of exons on the primary RNA transcript (henceforth,
pre-mRNA) will get spliced into the mature mRNA
isoform, is mediated by a combination of cis-regulatory
elements organized across exons and introns (1), quite
analogous to the cis-regulation of transcription. Global
identiﬁcation of splicing regulatory elements has been
diﬃcult and has been primarily restricted to exonic elements
(2–6), while limited computational information is available
on intronic elements (7–13). However, availability of
splicing microarrays (14–16), which can interrogate expres-
sion levels of exons genome-wide under any particular
biological condition, has opened up new possibilities. In this
work, we demonstrate that one can now apply analogous
computational approaches used for dissecting transcrip-
tional regulation (17) to decipher the splicing regulatory
elements, with genes replaced by exons and promoters by
pre-mRNA regions proximal to the splice sites.
A new set of approaches based on correlation with
expression has been particularly successful in identifying
cis-regulatory elements governing transcription (18–21).
Here, the premise is that gene expression results from
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as mediated by binding of trans-factors to the cis-elements.
This implies that for an active cis-regulatory motif, its
parameters [occurrence frequencies and position weight
matrix (PWM) scores] must be signiﬁcantly correlated
with the expression levels across genes under any speciﬁc
biological condition. Multiple studies have established
that, using this strategy, one can identify the motifs that
are functional under the tested condition. Furthermore,
expression data from a single test condition and a
reference condition are often suﬃcient for the analysis.
In addition, unlike clustering-based approaches, interact-
ing combinations of motifs can be inferred with high
conﬁdence (19,22). Finally, a recent study based on linear
splines, which model the sigmoidal nature of transcrip-
tional response, shows that such approaches can accu-
rately identify direct targets of trans-factors binding to the
active motifs, even when the motifs are very degenerate
(22). Target identiﬁcation in such situations has been quite
challenging. Thus, one can delineate the key elements of
transcriptional regulatory networks using correlation with
expression. This has proven eﬀective in both lower
eukaryotes, e.g. yeast (18,19,23), and in mammals (22).
Here we report the ﬁrst application, to our knowledge,
of the correlation with expression approach for identiﬁca-
tion of cis-elements that regulate alternative splicing by
integrating pre-mRNA sequence information with the
exon microarray data. Speciﬁcally, we focused on tissue-
speciﬁc splicing, as tissue-speciﬁc pre-mRNA regions are
largely conserved across species (8,24,25), and thus,
phylogenetic conservation can be used to evaluate the
predictions. We employed an Aﬀymetrix exon microarray
(26) to identify 56 muscle-enriched alternative cassette
exons, a number of which are predicted to alter the
expression of cytoskeletal related genes. We used both
linear regression (18) and linear splines (22) to examine
whether cis-elements in introns adjoining these exons
correlate with gene-normalized exon expression in muscle.
Multiple motifs that demonstrated statistically signiﬁcant
correlation were also found to be conserved in mouse,
chicken and frog. In addition, several of these elements
have been previously characterized experimentally as
regulators of muscle-speciﬁc splicing via binding to
members of the Fox (27–33), CELF (34) and PTB (35)
families of splicing factors. Taken together, our study
shows that correlation with expression is indeed eﬀective
in deciphering splicing regulatory elements, and provides
the most comprehensive picture yet available of muscle-
speciﬁc alternative splicing program in humans.
MATERIALS AND METHODS
Identification of muscle-enriched alternative exon
andcontrol exon datasets
Total RNA from three biological replicates (three separate
individuals) of 16 normal adult human tissues was
purchased from BioChain (Hayward, CA, USA). Labeled
target was generated from  200ng of total RNA and
hybridizedtoaprototypeversionoftheAﬀymetrixHuman
Exon Array as described (26). The set of microarrays
contain  1.4 million probesets designed to interrogate,
as comprehensively as possible, more than 1 million exon
clusters derived from a variety of input sources including
annotated genes, cDNA sequences and exon prediction
algorithms. Design information and microarray data is
available at the GEO database (http://www.ncbi.nlm.nih.
gov/geo/; accession number: GSE5791).
Candidate muscle-enriched probesets were identiﬁed
using the splicing index approach (26,36,37). Exon-level
expression was normalized to the expression level of the
parent gene by dividing probeset intensities by the median
intensity of probesets from exons supported by RefSeq or
Ensembl annotations. Exons that exhibited statistically
signiﬁcant diﬀerences in inclusion rate were identiﬁed using a
student’s t-test on the gene-level normalized probeset
intensities (NI). NI values from the three biological
replicates of heart and skeletal muscle tissues were compared
as a group to the replicates of 14 other non-muscle tissues as
a second group. The magnitude of inclusion rate change
(splicing index) was estimated by calculating a log ratio (base
2) of the median muscle NI and the median non-muscle
NI (26,37). After ﬁltering out non-expressed probesets and
genes with low expression, probesets with t-test P-values
50.001 and splicing index magnitudes of 40.5 were
considered candidates for muscle-enriched exons.
Manual ﬁltering of the initial list was performed to
select further for high conﬁdence internal cassette exons,
by mapping candidate muscle-enriched probeset to their
genomic context using the BLAT tool (38) at the UCSC
genome browser (http://genome.ucsc.edu). Probesets that
overlapped annotated alternative transcriptional starts,
alternative polyadenylation sites, or regions with alter-
native 50 or 30 splice sites, were removed from considera-
tion in this study. Exon-level probeset intensities were
additionally observed using BLIS (Biotique Systems, Inc.
Reno, NV), an integrated genome browser that enables
exon expression data from the microarray to be viewed in
genomic context. Only probesets that showed clear
patterns of muscle enrichment were kept for further
analysis. Probesets had to demonstrate higher intensity
levels in the muscle tissues and have exon-level data for
surrounding probesets consistent with exon skipping in a
majority of non-muscle tissues. Probesets were subse-
quently mapped to the May 2004 human genome (NCBI
Build 35) using BLAT (38). Exact exon boundaries were
determined by comparison to EST and mRNA sequences
requiring consensus splice sites.
For phylogenetic analysis, the orthologous exons
were identiﬁed in another mammalian genome (mouse;
Mus musculus), in an avian genome (chicken; Gallus
gallus) and in an amphibian genome (frog; Xenopus
tropicalis) using VISTA alignment tools. Automatic
alignment was successful at ﬁnding most of the longer
alternative exons directly, but in a few cases the
alignments were adjusted manually. The upstream 200nt
(U200) intronic region was selected as the base 1 to base
200 adjoining the exon in the upstream direction, while
downstream 200nt (D200) intronic region was selected as
the base 1 to base 200 downstream of the exon.
Alignments of orthologus introns and exons sequences
were generated by LAGAN using default parameters (39).
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derived as described previously (8) from the European
Bioinformatics Institute database of human alternative
exons (http://www.ebi.ac.uk/asd/altextron/index.html).
‘Control exon datasets’ were generated from randomly
selected chromosomal regions by extraction from RefSeq
annotation databases to get exon coordinates. Control
groups for the mammalian and chicken genomes were
described previously (8). The muscle-enriched datasets
and the control datasets is available at: http://vision.
lbl.gov/People/ddas/NAR_SPLICE1/
Validation of muscle-enriched expression
A random subset of candidate muscle-enriched exons was
selected for validation by RT–PCR, focusing (for ease
of ampliﬁcation) on those 4155nt in length. RNAs from
diﬀerent human tissues, including heart, skeletal muscle
and six non-muscle sources, were purchased from
Clontech. One microgram of each RNA source was
transcribed into cDNA using random hexamer primers
in a total volume of 10 l. Then, 2 l cDNA was ampliﬁed
in a volume of 25 l, using primers located in the ﬂanking
constitutive exons (Supplementary Table 2), for 35 cycles
under the following conditions: 30s at 948C; 30s at 558C;
45s at 728C. The identity of PCR products was conﬁrmed
by DNA sequence analysis.
Correlation withexpression
Linear correlation. Counts of hexamers were obtained in
a speciﬁc pre-mRNA sequence region (upstream or
downstream proximal intron). For each region, a linear
model was ﬁtted between the logarithm of ratios of gene-
normalized exon expression levels and count of each 6-mer
word w across a set of exons, fne
wg:
logðNIe=NIeCÞ¼aw þ bwEne
w
NIe is the gene-normalized expression level of exon e in
muscle, and C refers to a reference sample. The reference
data was taken as the average NI across all tissues. The
coeﬃcients aw and bw were obtained by a least squares ﬁt.
P-values were calculated using an F-test, as described
previously (40).
The best ﬁt was obtained for a set of sequences that
included the muscle-speciﬁc exons (foreground set) and a
background set of m sequences (m=300), drawn ran-
domly from a set of manually curated 957 cassette exons
across the human genome (11). Since we started with a
prioritized set of tissue-enriched sequences, a background
set was necessary to model the correct dependence of log
ratios on word count. n such random draws were
performed (n=25), and a linear ﬁt was obtained for
each such draw. A geometric mean of the P-values from
all iterations reﬂects the overall signiﬁcance of the word.
Linear splines. Linear splines diﬀer from lines by intro-
ducing a threshold, called knot, below which the function
is constant and linear above it (19,22). A signiﬁcant
diﬃculty in modeling binding sites via PWMs is that they
give rise to a continuous distribution of scores across all
possible binding sites. Consequently, a cutoﬀ score needs
to be determined to discriminate the true sites from false
sites. Such cutoﬀ scores are often based on predetermined
background sequences and thresholds, and as a result,
are complicated by subjective choices (41). In a linear
spline model, the cutoﬀ score corresponds to the knot, and
thus, is learnt directly from the input data (22). For each
PWM   of width L, each L-mer in the input sequence was
assigned a probability score M:
M ¼ p1 b1 ðÞ p2 b2 ðÞ ...pL bL ðÞ ½ 
1=L
where pi(bi) is the probability of observing the base bi at
the position i. Thus, the score M always assumes a value
between 0 and 1. It is related to binding aﬃnity (42).
PWM scores across exons fM 
e g for a given motif   were
ﬁtted to the splicing ratios log NIe=NIeC ðÞ
  
using the
following model:
log NIe=NIeC ðÞ ¼ a  þ b 
X
M
 
e 4  
  M 
e     ,0
  
where  (x,0) is a linear spline: it is x, when x50, and zero,
otherwise.   , termed knot, corresponds to the cutoﬀ
score. The coeﬃcients a  and b  and the location of the
knot    were determined by a least squares ﬁt. This leads
to an unbiased and adaptive determination of the knot   
for any given PWM. Importantly, in contrast to previous
approaches (22), where contribution from only the
maximum scoring site was considered, we systematically
accounted for contribution from active sites with weaker
scores as well. The number of such active sites is
adaptively learnt, as displayed in the equation above.
Thus, both binding aﬃnity and occurrences of active
motifs are accounted for in our approach. The signiﬁcance
of the ﬁt was assessed using an F-test (40). The overall
signiﬁcance of each PWM was enumerated using the
same iterative procedure as for the linear regression
discussed above.
Over-representation analysis
RNA words. We examined over-representation of candi-
date oligonucleotide sequences (RNA words) in each
tissue-speciﬁc dataset, relative to the control datasets,
using a hypergeometric distribution. The results were
corrected for multiple testing using the false discovery rate
(FDR) method (43). The results of this test were generally
consistent with the non-parametric approach that we have
described previously (7). Furthermore, for each word a
contrast score was also calculated as the diﬀerence in
frequency in the tissue-speciﬁc dataset versus the control
dataset. Similar results were obtained using two control
sets, one composed of predominantly constitutive exons,
and the other containing alternative but nontissue-speciﬁc
exons (8). Like standard motif analyses, repeat elements
were not explicitly excluded from this analysis. They are
automatically ﬁltered by the correlational analyses.
Moreover, only non-overlapping motifs were counted in
the word frequency calculations. Manual examination of
the sequences revealed no cases of long repeating elements
that would inﬂuence frequency calculations of the
candidate regulatory motifs.
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DME (Discriminating Matrix Enumerator) algorithm
(44,45). DME is an enumerative search algorithm that
ﬁnds the PWMs over-represented in a foreground set
relative to a background set. Both intronic regions
(upstream and downstream) were searched for over-
represented matrices of width 6nt, using the background
sets as above. Default parameter settings were used, except
that we varied the average information content of the
PWM from 1.0 to 2.0 in steps of 0.1. Fifteen PWMs were
obtained for each such setting. Correlation analysis was
performed on non-redundant sets of matrices. Matrix
similarity was assessed using MatCompare (46).
RESULTS
Identification and characterization of muscle-enriched
alternative exons
The human muscle-enriched exon dataset analyzed in this
study (Supplementary Table 1) was derived from exon
microarray hybridization data using a platform designed
to provide a comprehensive genome-wide analysis of
annotated and predicted exons (see Methods section).
In order to identify motifs that regulate tissue-speciﬁc
alternative splicing, it is critical to identify a set of
alternative exons having similar expression patterns
indicative of regulation by a shared splicing program.
Therefore, the group of exons studied here was carefully
selected by analysis of exon microarray data from a panel
of 16 normal adult human tissues. Probesets that exhibited
gene-level NI that were signiﬁcantly higher in heart and
skeletal muscle, relative to 14 other tissues, were ﬁrst
identiﬁed. For this part of the analysis, we grouped the
heart and skeletal muscle exon expression together to
enhance the power of the statistical tests. Then a manual
ﬁltering process was performed so as to retain only
probesets representing cassette exons, and to eliminate
probesets corresponding to alternative ﬁrst and last exons
or to exon regions generated from alternative 50 and 30
splice sites. The ﬁnal dataset consisted of 56 muscle-
enriched, internal cassette exons. Most of these exons
( 80%) are integral multiples of 3nt in length, with a
median length of 84nt, consistent with the notion that
alternative exons are smaller than average constitutive
exon length [ 145nt (47,48)]. However, the genes with
such alternative exons have a median size of 123kb, much
longer than the average gene length. To explore evolu-
tionary conservation of candidate splicing regulatory
elements, we also identiﬁed highly conserved orthologs
for most of these human muscle-enriched exons in mouse,
chicken and frog (Supplementary Table 1). It is important
to note that while many of these exons show evidence of
alternative splicing in Genbank, most were not previously
known to exhibit muscle-enriched splicing and were not
identiﬁed in the pilot study of muscle-enriched exons by
Sugnet et al. (11). Therefore, analysis of this dataset
should yield novel insights into the vertebrate muscle
alternative splicing program, and should provide an
opportunity to explore computationally the regulatory
motifs that carry out this program.
Muscle-enriched splicing patterns for a random subset
of these exons were validated experimentally in the human
dataset by RT-PCR (Figure 1). Although splicing patterns
were not absolutely muscle speciﬁc, in almost every case
1 2 3 4 5 6 7 8 2 1 3 4 5 6 7 8
DYSF ABLIM
FAT LRRFIP2
LRRFIP1 MFN2
ITGB1 ANK2
TMEM16E UNR
BRAF CACNB1
ACAS2 CLASP1
MTMR3 PPP1R12A
SVIL
Figure 1. Validation of microarray predictions of muscle-enriched alternative exons. RT-PCR conﬁrmation of muscle-enriched alternative exon
expression. Ampliﬁcations were performed using primers in the ﬂanking constitutive exons. RNA sources used for ampliﬁcation by lane number:
1, brain; 2, kidney; 3, liver; 4, stomach; 5, bone marrow; 6, testis; 7, heart; 8, skeletal muscle. Arrowheads indicate positions of the alternative exon
inclusion products that are most enriched in heart and skeletal muscle.
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skeletal muscle, conﬁrming the predictions of the exon
microarray. Importantly, mRNA and/or EST evidence
from the genetic databases (data not shown) demonstrates
that the majority of these exons are alternatively spliced in
at least one of the other species examined (mouse, chicken
or frog), suggesting that the incidence of conserved
alternative exons in this specialized dataset is higher
than the reported rate for general alternative exons (49).
Taken together, these results indicate that the muscle-
enriched exons constitute a special class of highly
conserved alternative exons.
Intron sequences ﬂanking orthologous alternative exons
in the mouse and human genomes tend to be evolutiona-
rily conserved (24), consistent with the observation that
cis-regulatory elements for tissue-speciﬁc alternative splic-
ing are often located in those proximal intron regions. We
used VISTA genome alignment tools to compare the
proximal intron sequences in this muscle-enriched dataset
and extended the evolutionary comparison to include
chicken and frog. In the proximal 200-nt upstream (U200)
and downstream (D200) introns, mouse sequences were
highly similar to their human orthologs (median identity
of 61 and 58%, respectively), while chicken and frog
introns were much less homologous. The full quantitative
data are shown in Supplementary Table 3 and representa-
tive alignments of exons with relatively high conservation
(FXR1), or lower conservation restricted mainly to the
exon (LRRFIP1), are displayed in Figure 2. The reduced
overall homology of chicken and frog introns suggests
that conserved motifs in these regions are likely conserved
speciﬁcally for their function as cis-regulatory elements for
muscle-speciﬁc alternative splicing, rather than being
passively conserved as part of a larger conserved element.
Frequent occurrenceof muscle-enriched exons in genes
encodingproteins withfunctions in cytoskeletal organization
Previous studies have demonstrated that the brain-speciﬁc
alternative splicing factor, NOVA1, modulates the splicing
of many components of the neuronal synapse (50).
We hypothesized that the muscle alternative splicing
program might similarly coordinate the expression of a
particular class of genes that share a common pathway or
cellular process. Using the method described previously
(22,51), to examine the gene ontology (GO) terms
associated with each parent gene for the muscle-enriched
exons, we found a strong association with cytoskeleton
organization and biogenesis, microtubule stabilization and
muscle development (Supplementary Table 4). These
associations were statistically signiﬁcant (P50.001), sug-
gesting that the muscle alternative splicing program is
critical for proper expression of the unique cytoskeleton
characteristic of vertebrate muscle.
human exon (LRRFIP1)
mouse
chicken
frog
100% 
50%
100%
50%
100%
50%
441.35k 238,441.55k 238,441.75k 238,441.95k 238,442.15k 238,442.25k
human exon (FXR1)
mouse
chicken
frog
100%
50%
100%
50%
100%
50%
171.08k 182,171.28k 182,171.48k 182,171.68k 182,171.88k 182,172.08k
Figure 2. Conservation of intron sequences ﬂanking muscle-enriched exons. Representative VISTA genome alignments of exon and ﬂanking intron
sequences from the mouse, chicken and frog genomes with the prototypical muscle-enriched exon from human. Exon boundaries are indicated by
vertical lines. Shaded regions indicate sequences that exceed 75% identity, while curves above baseline indicate regions with 450% identity to the
human sequence.
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regulatory elements
Alternative splicing regulatory elements responsible for
tissue-speciﬁc splicing are often located in proximal intron
sequences (25). To search for candidate intronic regula-
tory motifs for the muscle-speciﬁc splicing program, we
correlated the frequencies of hexamers in speciﬁc intronic
regions with the logarithm of ratios of gene-normalized
exon expression levels in skeletal muscle, across the
56 muscle-enriched exons in the human dataset. The
ratio for any exon was enumerated against its average
gene-normalized expression level across all the tissues.
Thus, it is similar to the splicing index used above.
The cis-elements exhibiting signiﬁcant correlation with
expression were considered potentially functional in
regulating muscle-speciﬁc splicing. These were further
examined for relative over-representation in introns of
muscle-enriched exons, compared to a background set
of introns ﬂanking constitutive exons, using a hypergeo-
metric distribution based on word counting in the oligo-
nucleotide sequences. Finally, we examined their spatial
conservation through vertebrate evolution (8) by testing
whether the motif is over-represented in the other species
using exactly the same statistical measures as used
for humans.
Here we consider UGCAUG in the downstream 200nt
(D200) of intron sequence as an example. This hexamer
represents the binding site for mammalian Fox-1 and
Fox-2 splicing factors (31), which have identical RRM
domains. UGCAUG has been reported as a common motif
in proximal introns adjacent to tissue-speciﬁc exons. In a
few cases, functional splicing assays have conﬁrmed the
importance of this motif in regulation of splicing (27–33).
In the large group of muscle-enriched exons studied here,
we found a highly signiﬁcant correlation of UGCAUG
frequency with muscle expression (P=6.8E 05). The
distribution and the linear ﬁt for a single iteration of
correlation analysis (see Methods section) are shown in
Figure 3A. Similar analysis shows that muscle expression
does not correlate with UGCAUG occurrences in the
upstream intron, whereas in the downstream intron the
magnitude of correlation decreases with distance from
the exon as demonstrated by the increasing P-values
(Figure 3B). These dependencies are further corroborated
by strong over-representation of this motif in proximal
downstream introns in human and other vertebrates
(Figure 3C). Indeed, almost half of the muscle-enriched
exons in all four datasets (23/56 in human, 21/54 in
mouse, 20/43 in chicken and 19/36 in frog) possessed
at least one UGCAUG motif in the ﬁrst 200nt of the down-
stream proximal intron. Together, these results strongly
support the hypothesis that UGCAUG is potentially an
important regulatory element for muscle-speciﬁc alter-
native splicing, as predicted by the correlation with
expression analysis.
Analysisof upstream and downstream intron sequences
We extended the above analysis to identify additional
muscle-speciﬁc cis-elements in upstream and downstream
intron sequences. In the downstream 200nt sequence,
we searched all possible hexamers and identiﬁed a total
of 35 hexamers that were signiﬁcantly correlated with
expression (P40.05) and also over-represented in the
human dataset (P40.05, q40.2); nine of these were also
over-represented in at least one other species (Table 1A
and Supplementary Table 5A). Several of these elements
have been previously characterized experimentally as
regulators of muscle-speciﬁc splicing. These motifs fell
into three distinct classes: (i) the Fox1/2-binding motif
UGCAUG (P=6.8E 05) and two closely related hexamers
(GCAUGG, UUUGCA); of note, in all four species the majority
(58–76%) of GCAUG motifs in the D200 region
occurred in the context of the full UGCAUG hexamer.
(ii) UG-rich elements GUGUGU and UGUGUC (correlation
P-values=0.032 and 0.005, respectively), that resemble
binding sites for the CELF family of splicing factors; and
(iii) the novel motif ACUAAC (P=0.0006) and related
hexamers CUAACC (P=0.004) and CACUAA (P=0.04). The
latter class is similar to the UACUAAC element noted in
a recent study of a small group of muscle-speciﬁc exons in
mouse (11). The distribution of these elements in ﬂanking
introns of exons in the human, mouse, chicken and frog
datasets is shown in Figure 4A. Importantly, this analysis
revealed that UGCAUG was the most over-represented
hexamer in all four datasets, and both GUGUGU and
ACUAAC were also consistently in the top  1% of the most
over-represented hexamers in these species.
For upstream intron sequences (200nt), we found a
total of 27 hexamers that were signiﬁcantly correlated
with expression and also over-represented in human, of
which three were over-represented in at least one
other species (Table 1B and Supplementary Table 5B).
Many such elements are strongly pyrimidine-rich, char-
acteristic of binding sites for PTB protein, an inhibitor of
splicing for many alternative exons (35). In all four
species, the muscle-enriched datasets showed strong over-
representation of the reported PTB-binding sites, CUCUCU
and UCUU, in the proximal upstream intron (Figure 4).
CUCUCU was concentrated mainly in the U200 region.
UCUU was focused even more tightly in the U100 region
(Figure 4B), where it was consistently among the top ﬁve
over-represented tetramers in all four species. Lesser over-
representation of UCUU motifs over a broad area of
downstream intron sequences was also noted, perhaps
consistent with previous ﬁndings that optimal splicing
repression by PTB requires binding sites both upstream
and downstream of the regulated exon (52,53).
Many of the remaining signiﬁcant hexamers, both for
upstream and downstream introns, have low similarity to
the previously discovered elements. Although these may
represent novel elements, given that splicing elements are
often degenerate, they can also be speciﬁc examples of
known degenerate motifs. Our analysis using degenerate
motifs presented below suggests that the latter possibility
is more likely. Finally, for some of the major splicing
regulatory elements described above, we observed that the
proﬁles of positional over-representation have been
conserved through vertebrate evolution: mouse, chicken
and frog. This is displayed in Figure 4 for Fox, CELF and
PTB-binding sites. Such strong positional conservation of
4850 Nucleic Acids Research, 2007, Vol. 35, No. 14motifs lends additional support to our ﬁndings using
correlation with expression.
The Fox-binding site, UGCAUG, was previously shown to
be over-represented downstream of brain-enriched alter-
native exons (7,8), raising the possibility that the brain-
and muscle-speciﬁc alternative splicing programs might
exhibit functional similarities by sharing related compo-
nents of the splicing machinery. To determine which of the
candidate muscle cis-regulatory elements might be shared
with brain-speciﬁc alternative splicing, and which are
unique to the muscle program, we compared the frequency
of several key cis-regulatory motifs in muscle (this study)
and brain (8) datasets. Two elements, ACUAAC and
UGUGUG, were clearly muscle speciﬁc since their frequen-
cies were consistently higher in the D200–D300 region
adjacent to muscle-enriched exons compared with the
intronic region downstream of brain-enriched exons
(Supplementary Figure 1; positive contrast scores).
These motifs were also not over-represented in brain
relative to control exons (data not shown). In contrast, the
motifs UGCAUG and CUCUCU occurred at even higher
frequencies in the proximal introns of the brain-enriched
dataset than they did in the muscle-enriched dataset
(Supplementary Figure 1; negative contrast scores for
UGCAUG in the D200–D400 region, and for CUCUCU in the
U100 region). Essentially equivalent distribution patterns
were observed in the mouse, chicken and frog datasets
(data not shown). These results strongly suggest that
tissue-speciﬁc alternative splicing programs may utilize a
combination of unique and shared cis-regulatory motifs
that will require much additional analysis in the future.
Motifs identified via PWM analysis are consistent
withword analyses
Because many splicing factors bind degenerate oligonu-
cleotide sequences in RNA, we extended our analyses to
include degenerate motifs through the use of PWMs
(3,54). PWMs are probabilistic representations of degen-
erate binding sites. Over-represented PWMs in introns of
56 muscle-speciﬁc exons in the human dataset were
obtained using the DME algorithm (44,45). We scanned
multiple parameter settings of DME in order to obtain a
large number of PWMs and reduce bias from DME.
To identify the functional PWMs, we assessed their
correlation with muscle expression using linear splines
(19,22). Linear splines are among the simplest non-linear
variants of linear models. In contrast to many other
approaches, they facilitate adaptively learning the cutoﬀ
scores of PWMs that discriminate true targets from false
targets of trans-factors. Previous regression approaches
have used either maximum score of the PWM (22) or a
global average of PWM scores for all potential binding
sites (20) on an input sequence as the predictor variable.
However, realistically, a small number of sites, sometimes
41, are bound by the corresponding trans-factor. Here we
overcame this limitation by including both strength of
PWM and the number of putative binding sites in our
linear splines approach (see Methods section).
Table 1. Signiﬁcant words identiﬁed by linear correlation analysis. Top 10 words in (Panel A) downstream and (Panel B) upstream introns
(length=200nt).
Word Correlation analysis P-value Over-representation analysis Contrast score Phylogenetically conserved? Putative trans-factors
P-value q-value
Panel A: D200
UGCAUG 6.8E 05 1.7E 15 6.1E 12 0.0024 Frog, mouse, chicken Fox-1
ACUAAC 0.0006 2.5E 08 2.3E 05 0.0008 Frog, mouse, chicken
 
GCAUGG 0.0006 3.6E 05 0.004 0.0009 Mouse Fox-1
CGUGUG 0.0007 0.009 0.12 0.0005 CELF
GCAUGA 0.002 0.002 0.04 0.0006 Fox-1
AGCAUG 0.002 0.0007 0.02 0.0007 Fox-1
UAACCC 0.003 9.6E 05 0.008 0.0006
CUAACC 0.004 2.9E 05 0.004 0.0007 Frog
 
CACCAA 0.005 0.005 0.08 0.0004
UGUGUC 0.005 0.006 0.09 0.0007 Chicken CELF
Panel B: U200
CCCCUU 0.002 9.8E 05 0.004 0.0009
UUUCCA 0.002 0.0006 0.02 0.0009 PTB
UCCUCC 0.002 8.3E 05 0.004 0.0007
UCUCCA 0.002 0.0002 0.007 0.0006
AUCUCC 0.003 0.02 0.19 0.0002
CCCCCU 0.003 0.03 0.2 0.0004 Frog PTB
UCUUUC 0.004 1.1E 07 1.8E 05 0.0020
CUCCUC 0.006 0.003 0.05 0.0004
UCAUCU 0.007 0.001 0.02 0.0005
AAAUCU 0.009 0.003 0.05 0.0005
Asterisk indicates the previously identiﬁed, but as yet uncharacterized, novel element ACUAAC. q-value indicates multiple testing correction using the false
discovery rate (FDR) method (43). Phylogenetic conservation was assessed by examining relative over-representation of each word in each species and
employing the same P-value cutoﬀs as in human (P40.05, q40.2). Complete list of signiﬁcant words is shown in Supplementary Table 5.
Nucleic Acids Research, 2007, Vol. 35, No. 14 4851Degenerate 6-nt and 4-nt sequences that were over-
represented in the proximal downstream intron sequence
are shown in Table 2A and B and Supplementary
Table 6A and B. Notably, all of the top 10 over-expressed
PWM hexamer motifs in the D200 region are consistent
with the major over-expressed unique motifs identiﬁed
above. Among these, the six most statistically signiﬁcant
motifs represent close matches to the Fox-binding site,
UGCAUG; two (NHCUAA and HCUAAN) are very similar to the
novel ACUAAC element; and the remaining motifs (SUKUGS
and CUGYSR) resemble UG-rich-binding site for CELF
proteins. Analysis of over-expressed 4-mers in the D50
region revealed that the top-scoring motif is UGCM.
While this motif is included in the Fox recognition
sequence, other considerations suggest that it would not
be suﬃcient for Fox binding. Instead, UGC likely
represents the CUG-rich sequences, characteristic of some
CELF-binding sites.
In the U200 region, all of the statistically over-
represented motifs were quite pyrimidine-rich relative to
the control group (Table 1B and 2C). Further investiga-
tion will be required to determine whether these elements
are primarily bound by the PTB protein or by additional
splicing factor(s). All remaining PWMs that have high
signiﬁcance in upstream and downstream introns exhibit
at least partial similarity to the above three elements.
C
0
0
1
2
3
4
5
6
0 100 200 400 500
-
l
o
g
 
(
p
)
E B
A
−6
−4
−2
0
2
4
6
1 02 3 4
l
o
g
2
 
(
N
I
e
/
N
I
e
,
a
v
g
)
−500 −400 −300 −200 −100 300
−1
0
1
2
3
4
−500 −400 −300 −200  100 100 200 300 400 500
C
o
n
t
r
a
s
t
 
s
c
o
r
e
Human Mouse Chicken Frog
UGCAUG count
E
downstream intron Upstream intron
E
Figure 3. Correlation with exon expression for the UGCAUG regulatory element. (A) Linear ﬁt between ratios of gene-normalized exon expression
levels and counts of UGCAUG in 200nt of downstream intronic sequence across 356 exons (56 muscle-speciﬁc exons and 300 randomly selected exons)
(P=4.6E–06). (B) Dependence of correlational P-values of UGCAUG count with distance. Filled circles indicate correlation with total motif count,
while unﬁlled boxes indicate correlation with bin-wise count (bin size=100nt). E.g. for 300nt, the ﬁlled circle reﬂects the strength of correlation with
the count in 1–300nt of intron, while the unﬁlled box reﬂects the correlation with the count in 201–300nt of intron. Minus sign indicates upstream
intron. (C) Contrast scores of UGCAUG in upstream and downstream introns of human, mouse, chicken and frog. (‘E’ in Figure 3B and 3C indicates
position of the exon).
4852 Nucleic Acids Research, 2007, Vol. 35, No. 14For PWMs with only partial similarity, the similarity is
observed either at the 50 or at the 30 end of the motif,
indicating that the remainder of the motif most probably
represents the ﬂanking region. For example, for the
PWM RRWGCA, the last four bases match the
50 end of the UGCAUG, and hence, the ﬁrst two bases are
presumably the ﬂanking region of this putative Fox-
binding motif.
Furthermore, in contrast to previous work (22), the new
formulation of linear splines used here allowed us to
obtain not only the potential target exons, but also the
binding sites of the above splicing factors (see Methods
section). The results for a representative set of motifs
are summarized in the Supplementary Table 7. For the
putative Fox-binding motif WGCAUK, we ﬁnd UGCAUG as
the most frequently occurring oligonucleotide sequence,
as expected of Fox-binding sites. We have observed
similar accuracy in binding site prediction in the context
of transcriptional regulation (Das,D., unpublished data).
Interestingly, we notice that not all possible combinations
of nucleotides of a degenerate PWM are realized in the
set of 56 muscle-speciﬁc exons. For example, for the
candidate CELF-binding motif, CUGYSR, only CUGUGA is
predicted as the binding site. These are consistent with the
previous observations made in the context of transcrip-
tional regulation (55,56).
Table 2. Signiﬁcant position weight matrices (PWMs) identiﬁed by
correlation analysis using linear splines.
Consensus P-value Sequence logo
Panel A: D200
WGCATK 2.3E 07
WGMHTD 3.4E 07
GCATRN 8.2E 07
DWGCAT 3.1E 06
NWGMWT 3.7E 06
WGHHTD 7.1E 05
NHCTAA 1.2E 04
STKTGS 2.0E 04
CTGYSR 3.4E 04
HCTAAN 3.4E 04
Panel B: D50
TGCM 4.8E 04
GCAT 2.8E 03
CTTG 0.04
(Continued)
Table 2. Continued.
Consensus P-value Sequence logo
Panel C: U200
VYCCHT 9.5E 05
YMCYYN 1.1E 04
TYYCCM 5.1E 04
CCCTNM 8.7E 04
YMCYYW 9.0E 04
Panel A: Top 10 PWMs of width 6nt in proximal downstream intron
sequences (length=200nt).
Panel B: All signiﬁcant PWMs of width 4nt in proximal downstream
intron sequences (length=50nt).
Panel C: Top 10 PWMs of width 6nt in upstream intron sequences
(length=200nt). Complete list of signiﬁcant PWMs in downstream
and upstream 200nt introns is shown in Supplementary Table 6.
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In this study we have demonstrated that the correlation
with expression approach, applied to global exon expres-
sion proﬁles, represents a powerful new tool for identiﬁca-
tion of cis-regulatory motifs for alternative splicing. Using
a dataset of high-conﬁdence muscle-enriched alternative
exons extracted from human exon microarray data, we
correlated motif occurrences in the ﬂanking introns with
the splicing index measure of relative muscle enrichment
to identify candidate regulatory motifs for the muscle-
splicing program. The logic of this strategy is supported
by many studies of transcriptional regulation, and a few of
splicing regulation (57), showing that functional response
often correlates with regulatory motif copy number. The
analysis presented here demonstrates that the number of
Fox splicing factor binding sites (UGCAUG) correlates
strongly with the muscle splicing index (Figure 3A),
consistent with previous reports that Fox proteins can
regulate various tissue-speciﬁc alternative splicing events.
The validity of correlation results were further supported
by over-representation analysis, by comparative genomics
showing that top scoring correlation motifs are phyloge-
netically conserved among vertebrate genomes, and by
previous experimental studies implicating most of the
same motifs in regulation of muscle-speciﬁc exon(s).
Since tissue-speciﬁc alternative splicing is rarely an all
or nothing phenomenon (e.g. Figure 1), correlation with
expression may oﬀer an attractive approach toward
understanding complex tissue-speciﬁc patterns of alter-
native splicing. This approach may be particularly
eﬀective when PWMs are utilized in the splines-based
framework to account simultaneously for both relative
aﬃnity and number of motif occurrences, providing
insight into both the target exons and binding sites
associated with a given motif.
Our immediate goal here in this proof of concept study
was to examine whether the correlation with expression
method can be used to identify splicing regulatory motifs,
and consider muscle-speciﬁc alternative splicing program
as an example of this application. This analysis strongly
implicated several classes of known regulatory factors
including Fox (UGCAUG), CELF (GUGUGU and UCUGUG),
PTB (CUCUCU and UCUU) and putative KH-type splicing
factor (ACUAAC) as important mediators of muscle-
enriched splicing. The current study thus conﬁrms and
substantially extends earlier reports that these factors can
regulate one or a few muscle-enriched exons by providing
signiﬁcant new computational evidence that they correlate
with muscle exons in a much larger dataset. Interestingly,
there was a notable lack of novel cis-elements in the
proximal ﬂanking introns that strongly correlate with
muscle expression across the entire dataset. This could
indicate that much of the fundamental machinery for
regulation of generalized muscle-enriched splicing has
been identiﬁed or, more likely, that additional features
need to be incorporated in the algorithms to identify the
remaining components. Such features may include wider
motifs and motifs located more distally from the regulated
exons. It is also possible that there are weaker elements,
which may only be revealed when combinatorial
interactions among motifs are included in the regression
models, or which may be required for spatially or
temporally distinct subsets of muscle-enriched exons.
To obtain an initial estimate as to which of these
factors may be most inﬂuential, we extended our study
to include PWMs of width 5–7nt. The results are
displayed on our website (http://vision.lbl.gov/People/
ddas/NAR_SPLICE1/). We observe that most motifs
have similarities to the known motifs as identiﬁed above.
There is one motif in D200, GGSYVYW, which seems
novel. But since it has much higher P-value than others
(P=0.01), it is not readily clear if it is truly functional.
Hence, we suspect that inclusion of combinatorial inter-
actions among motifs may be most eﬀective in revealing
the novel motifs. One question that needs to be addressed
in future studies, as improved measures of binding
speciﬁcity become available, is the importance of addi-
tional splicing factors such as the muscleblind proteins
that are already known to inﬂuence the splicing of at least
a few muscle-speciﬁc alternative exons (51).
A working model that summarizes these ﬁndings is
presented in Figure 5. Fox, CELF and ACUAAC-binding
factors are proposed as positive regulators of muscle-
enriched exons via their binding to the downstream
proximal intron. The distribution of binding motifs
among individual introns suggests that these factors
function independently in some cases, and collaboratively
in others, to specify muscle-enriched splicing. For Fox
proteins an especially widespread role is suggested by the
high absolute abundance of UGCAUG-binding motifs:
almost half of the muscle-enriched exons in datasets of
all four species possess at least one UGCAUG motif in the
D200 intronic region, and some of those lacking a
proximal UGCAUG have phylogenetically conserved distal
UGCAUG motif(s) (data not shown) analogous to the
myosin II heavy chain-B neural speciﬁc exon (58). It will
be interesting in the future to explore how coordination
among these and other factors ultimately determines the
spatial and temporal details of muscle-enriched splicing
events. Based on studies in other systems, PTB is predicted
as a negative regulator of splicing, functioning primarily
from upstream intronic sites to prevent inappropriate
inclusion in non-muscle cell types (35,59,60). Finally, it is
important to note that variations of this general model
likely pertain to individual exons; in particular, Fox and
CELF proteins can also have a negative role in the
regulation of exons that are skipped in muscle (27,61–63).
Future experimental analysis of these splicing factors,
using functional splicing assays and targeted disruption of
splicing factor activity in vivo (64), will be required to more
fully test the predictions of this model.
Some of the cis-regulatory elements associated with
muscle-enriched alternative exons have previously been
observed ﬂanking brain-enriched exons: UGCAUG was the
most over-represented motif in proximal downstream
intron (7,8,11), and CUCUCU was the second most over-
represented motif in the U100 region upstream of brain-
enriched exons (7). These observations suggest general
roles for Fox- and PTB-related proteins in regulating
tissue-speciﬁc splicing, at least for muscle and brain, but
raise the question as to how tissue speciﬁcity is ultimately
4854 Nucleic Acids Research, 2007, Vol. 35, No. 14determined. Several mechanisms may contribute to
determination of temporal and spatial pattern of
splicing switches, including tissue-speciﬁc diﬀerences in
transcription and/or alternative splicing of Fox and
PTB paralogs (28). Diﬀerential expression of additional
RNA-binding proteins, such CELF proteins and KH-type
ACUAAC-binding proteins in muscle, or NOVA1-related
proteins in brain, likely also play a role, as may non-
RNA-binding co-factors that preferentially interact with
paralogs/isoforms of the primary RNA-binding proteins.
4 A
B
2
0
UGCAUG
E
0
2
4
UGUGUG
E
c
o
n
t
r
a
s
t
 
s
c
o
r
e
 
(
x
1
0
3
)
0
2
4
E
ACUAAC
CUCUCU
0
2
4
E
E
UCUU
0
8
16
0
800 600 400 200 0 200 400 600 800 1000 1000
E
UAGGG
0
2
4
upstream downstream
E
human   mouse   chicken    frog  
0
15
30
UGC
E
400 300 200 100 0 100 200 300 400
c
o
n
t
r
a
s
t
s
c
o
r
e
(
x
1
0
3
)
500 500
upstream downstream
E
human mouse chicken frog
Figure 4. Phylogenetic conservation of regulatory motifs in the proximal intron sequences. Bar graphs show the over-representation of the indicated
cis-regulatory motifs in the proximal intron sequences for muscle-enriched exons in four vertebrate species. (A) Enrichment of selected regulatory
motifs in 1-kb ﬂanking intron regions. The highest abundance of UGCAUG, UGUGUG and ACUAAC elements is consistently within the proximal
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Nucleic Acids Research, 2007, Vol. 35, No. 14 4855In summary, normal metazoan development requires
not only a transcriptional program, but also an alternative
pre-mRNA splicing program to ensure that each gene
encodes speciﬁc protein isoforms in the appropriate
spatial and temporal patterns. Enrichment within the
muscle dataset of genes with functions in cytoskeleton
organization, microtubule stabilization and muscle devel-
opment supports the notion that this splicing program is
essential for proper expression of the unique muscle
cytoskeleton. The exon microarray employed in this study
will enhance our ability to track the expression of
individual exons during development and diﬀerentiation.
As we have demonstrated here, this experimental
approach is well complemented by the computational
approach based on correlation with expression. We
anticipate that correlation with exon expression will
provide valuable insights into the cis-regulation of
alternative splicing as additional datasets of tissue-speciﬁc
exons become available for analysis.
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